Previous Article | Next Article ![]()
Journal of Virology, January 2008, p. 487-494, Vol. 82, No. 1
0022-538X/08/$08.00+0 doi:10.1128/JVI.01875-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

C5132 Veterinary Education Center, Department of Microbiology and Immunology, New York State College of Veterinary Medicine, Cornell University, Ithaca, New York 14853,1 The Marjorie B. Kovler Viral Oncology Laboratories, University of Chicago, Chicago, Illinois 606372
Received 27 August 2007/ Accepted 24 September 2007
|
|
|---|
|
|
|---|
In herpes simplex virus type 1 (HSV-1), the UL6, UL15, UL17, UL28, UL32, and UL33 genes are dispensable for assembly of capsids but required for viral-DNA packaging (2, 5, 7, 10, 15, 16, 19, 21). In cells infected with viral mutants lacking any one of these DNA-packaging proteins, DNA is not cleaved into genomic lengths from concatameric viral DNA. As viewed by electron microscopy, cells infected with such mutants lack DNA-containing capsids with electron-dense cores but contain capsids composed of two concentric shells. These capsids morphologically resemble B capsids, which lack DNA and are believed to be dead-end products of normal infection (13).
The roles that the respective DNA-packaging proteins play in the DNA-packaging reaction have been the focus of much recent study. Whereas the portal vertex is encoded by UL6 (14), the terminase is believed to comprise components encoded by UL15, UL28, and UL33. The products of these genes interact initially in the cytoplasm, followed by their importation into the nucleus through a nuclear localization signal within pUL15 (24). Evidence supporting the role of this protein complex as the terminase includes the following observations. (i) Mutations in UL28 that partly or completely disrupt the interaction between pUL15 and pUL33 preclude DNA cleavage and packaging (9, 21, 23). (ii) UL15 encodes a likely Walker box, which comprises a critical part of the active site of a subset of helicase-like ATPases and bacteriophage viral terminases (8, 12). Mutation of this site in HSV-1 precludes DNA cleavage and packaging (25). (iii) The UL28 protein has been shown to bind DNA known to be required for the formation of proper genomic termini (1). (iv) The UL15 protein has been shown to interact with the portal protein encoded by UL6 both in vitro and by coimmunoprecipitation from infected cells (22, 24). Thus, there is evidence supporting the DNA binding, ATP hydrolysis, and portal binding functions of the pUL15-pUL28-pUL33 complex, as would be expected of a viral terminase.
The studies reported here were undertaken to further characterize the phenotypes of viral mutants containing temperature-sensitive mutations in UL15 and UL33. The data provide insight into the nature of the pUL15-pUL28-pUL33 interactions and add further credence to the hypothesis that formation of the complex is essential for HSV viral DNA cleavage and packaging.
|
|
|---|
Plasmids, DNA sequencing, and Southern blotting. Plasmid pJB112 containing UL28 downstream of the human cytomegalovirus promoter in pcDNA3 has been described previously (23). The entire UL33 gene was amplified by PCR from HSV-1(mP) and ts8-22 DNAs and cloned into the HindIII and EcoRI sites of pcDNA3. The resulting constructs were designated pJB546 and pJB547, respectively. The UL33 genes in these plasmids were sequenced in their entirety using techniques described below. The viral genes UL15 exon I and exon II, UL28, and UL33 were also amplified by PCR from HSV-1(mP) and ts8-22 viral DNAs and sequenced.
DNA sequencing was performed by the Cornell University DNA Sequencing and Genotyping Core Facility using a mixture of BigDye terminator v3.1 and dGTP BigDye terminator v3.0 in a 3:1 ratio for cycle sequencing (Applied Biosystems, Foster City, CA), followed by dye terminator removal using Performa DTR gel filtration plates (Edge Biosystems, Gaithersburg, MD) and automated data collection by capillary electrophoresis using 3730xl DNA Analyzers (Applied Biosystems, Foster City, CA). Base calling was done using the ABI base caller, and quality scores were assigned using associated software. The generally accepted error rate for Sanger dideoxy sequencing is less than 0.1% in the optimal range of a given run.
Southern blotting was performed as described previously (5). Briefly, Vero cells were infected with 5.0 to 10.0 PFU per cell of the indicated viruses. At approximately 16 to 20 h after infection, viral DNA was purified, digested with BamHI, electrophoretically separated, denatured at high pH, and transferred to nitrocellulose. The blots were probed with radiolabeled BamHI S fragment of HSV-1 DNA, representing genomic ends. After being extensively washed, the bound probe DNA was visualized by autoradiography.
Marker rescue. The marker rescue experiments were performed as described previously (16). Briefly, HSV-1 DNA maintained in vector plasmids was obtained by restriction enzyme digestion, followed by extraction and purification from agarose gels. Rabbit skin cells grown in 25-cm2 flasks were cotransfected with HSV-1(mP) and ts8-22 viral DNAs and the various purified HSV-1 DNA fragments indicated in Tables 1 and 2. The cells were maintained at 34°C and were harvested when almost all cells exhibited cytopathic effects. Viruses obtained from each transfection were titered at 34°C and 39°C on Vero cells. Several viruses obtained from these experiments (listed in Table 2) that replicated at 39°C were plaque purified four times, and the stocks were expanded in Vero cells. The rescued viruses were characterized by efficiency of plating at 34°C and 39°C and the ability to cleave viral DNA as shown in Results.
|
View this table: [in a new window] |
TABLE 1. Marker rescue of HSV-1(mP ts8-22)a
|
|
View this table: [in a new window] |
TABLE 2. Designations and derivations of rescued viruses
|
Antibodies and coimmunoprecipitations. Rabbit antisera used for immunoprecipitations were directed against the N-terminal 35 amino acids of pUL15, the full-length pUL28, or the UL33 protein as previously described (6, 17, 20). The same antisera were used for immunoblotting, except that antibody directed against the C terminus of UL15, was used in lieu of the antibody directed against the N terminus of UL15 (5). The procedures for immunoprecipitation and immunoblotting were performed as described previously (23).
|
|
|---|
Several series of experiments were conducted to narrow the exact location of the mutation in ts8-22. In the first series of experiments, individual fragments from a library of cloned XbaI DNA fragments encompassing the entire HSV-1(F) genome were tested for the ability to rescue replication at 39°C using methods described previously (16). As shown in Table 1, the XbaI E fragment (diagrammed in Fig. 1, line 2) rescued the temperature-sensitive phenotype, whereas other fragments did not have such an effect (Fig. 1, line 2, and Table 1, experiment A). To narrow the site of the mutation further, fragments derived from HSV-1(F) DNA and spanning the XbaI E region were tested similarly, thereby localizing the temperature-sensitive mutation to the BamHI C' fragment (Fig. 1, lines 2 to 5, and Table 1, experiments B and C), which contains the UL33 and UL34 coding sequences. In the next series of experiments, smaller DNA fragments derived from both HSV-1(F) and HSV-1(KOS) DNA (Table 1, experiments D1 and D2, respectively) were used in the marker rescue assay. The results indicated that the fragment containing the UL33 open reading frame was sufficient to rescue the ts8-22 mutation (Table 2).
![]() View larger version (5K): [in a new window] |
FIG. 1. Colinear schematic diagram of DNA fragments used to map a novel lethal temperature-sensitive mutation in the ts8-22 viral genome. (Line 1) Diagram of the HSV-1 genome and XbaI E fragment. The open rectangles represent repeated sequences flanking the ends of unique long (UL) or unique short (US) sequences. The approximate site of the XbaI E fragment in the UL segment is indicated. (Line 2) Expanded diagram of the XbaI E fragment showing XbaI/BglII fragments screened for the ability to rescue the temperature-sensitive phenotype. The fragments are designated 1 and 2 as shown and in Table 1. (Line 3) Expanded fragment 1, as shown in line 2, illustrating BamHI sites. Fragment 1 contains the entire BamHI D, H, and H' fragments and truncated C' and O fragments. Truncations of the last two fragments are indicated by brackets. (Line 4) Expansion of the truncated BamHI C' fragment. The position of a NarI site used to divide the fragment into fragments 3 and 4 is shown. B, BamHI; Bg, BglII; N, NarI; X, XbaI.
|
![]() View larger version (18K): [in a new window] |
FIG. 2. Deduced amino acid sequences of UL33 from HSV-1(17), HSV-1(mP), and ts8-22. Bold characters indicate differences between sequences.
|
|
View this table: [in a new window] |
TABLE 3. Plating efficiencies and yields of HSV-1(mP), ts8-22, and rescued viruses at 34°C and 39°C after infection at 1.0 and 0.1 PFU/cell
|
![]() View larger version (39K): [in a new window] |
FIG. 3. Analyses of HSV-1(mP), ts8-22, or rescued virus genomic DNAs at permissive and nonpermissive temperatures. Vero cells were infected with the indicated viruses at 10 PFU per cell at 34°C or 39°C. Genomic viral DNAs were purified, digested with BamHI, transferred to nitrocellulose, and probed with radiolabeled BamHI S fragment, which is specific for sequences at genomic ends (fragments S), and internal junction fragments (fragments SP). (A) Cells were infected with the indicated viruses at 34 or 39°C as shown. (B and C) Cells were infected at 39°C with the indicated viruses. The precise origins of the rescued viruses are indicated in Table 2.
|
![]() View larger version (158K): [in a new window] |
FIG. 4. Electron microscopic images of thin sections of Vero cells infected with virus ts8-22 at permissive and nonpermissive temperatures. Vero cells were infected and were fixed 48 h later, embedded, sectioned, and stained with uranyl acetate. (A) Infection at 34°C. Virions with densely stained inner cores indicative of packaged viral DNA are present in the perinuclear space. (B to D) Images of cells infected at 39°C. Enveloped and unenveloped capsids lack densely staining inner cores. As a size standard, HSV-1 capsids are 125 nm in diameter.
|
As shown in Fig. 5, pUL15, pUL28, and pUL33 were readily immunoprecipitated with their cognate antibodies from lysates of cells infected with HSV-1(mP), ts8-22, and ts66.4 at the permissive and nonpermissive temperatures (Fig. 5A to C, lanes 2 to 7). As expected, the UL15, UL28, and UL33 proteins were not immunoprecipitated from mock-infected cells (lanes 1). Less pUL15 was immunoprecipitated from lysates of cells infected with ts66.4 and held at the nonpermissive temperature than from ts66.4-infected cells maintained at 34°C or from cells infected with HSV-1(mP) held at either temperature (Fig. 5A, compare lane 5 with lanes 2 to 4). Similarly, less pUL33 was coimmunoprecipitated from lysates of cells infected with ts8-22 and held at the nonpermissive temperature than from cells infected with wild-type virus or ts8-22 and held at 34°C (Fig. 5C, lanes 6 and 7). These data indicate that while incubation at the nonpermissive temperature reduced immunoprecipitation of some pUL15 and pUL33 with their cognate antibodies, the higher temperature did not completely abrogate this immunoprecipitation.
![]() View larger version (50K): [in a new window] |
FIG. 5. Immunoblots of terminase components immunoprecipitated from lysates of infected cells. (A) Cells were mock infected or infected at 34 or 39°C. At 16 h after infection, the cells were lysed and the clarified lysates were reacted with pUL15-specific antibody. Antigen-antibody complexes were purified, denatured, electrophoretically separated, transferred to nitrocellulose, and probed for the presence of pUL15 (top), pUL28 (middle), or pUL33 (bottom) by immunoblotting. Bound immunoglobulin was revealed using enhanced chemiluminescence and X-ray film (Amersham). (B) Same as panel A, except that cell lysates were reacted with pUL28-specific antibody. (C) Same as panel A, except that cell lysates were reacted with pUL33-specific antibody.
|
The effects of the pUL33 temperature-sensitive lesion on interactions between putative terminase components were as follows. (i) At the permissive temperature, pUL33-specific antibody readily coimmunoprecipitated both pUL28 and pUL15 (Fig. 5C, lane 6). Moreover, levels of pUL15 coimmunoprecipitated with pUL28 antibody were increased in cells infected with ts8-22 and held at the permissive temperature compared to similar reactions using lysates of cells infected with HSV-1(mP) or ts66.4 (Fig. 5B). (ii) Incubation of cells at the nonpermissive temperature precluded pUL15 and pUL28 from coimmunoprecipitation with pUL33 antibody (Fig. 5C). (iii) Very low levels of pUL28 were immunoprecipitated with the anti-pUL28 antisera from cells infected with ts8-22 and held at the nonpermissive temperature (Fig. 5B, lane 7). (iv) Smaller but readily detectable amounts of pUL15 were immunoprecipitated from lysates of cells infected with ts8-22 held at the nonpermissive temperature (Fig. 5A, lane 7), but the higher temperature precluded coimmunoprecipitation of pUL28 and pUL33 with pUL15 antibody (Fig. 5A, lanes 7). Despite the low levels of immunoprecipitable pUL28 in this lysate, the pUL28 antibody coimmunoprecipitated small amounts of pUL15 (Fig. 5B, lane 7).
Together, these data suggest that the temperature-sensitive lesion in UL33 precludes interaction of pUL33 with other terminase components at the nonpermissive temperature. The data also suggest roles for pUL33 in increasing steady-state levels of pUL28 and enhancing the interaction between pUL28 and pUL15.
Efforts were also made to assess the effects of the UL33 mutation on interaction with pUL28 in the absence of other viral proteins. Thus, CV1 cells were transfected with expression plasmids encoding pUL28 and pUL33 from either HSV-1(mP) or ts8-22. The cells were held for 24 h at 34 or 39°C, at which time they were lysed and subjected to immunoprecipitation with pUL28-specific antibody, followed by immunoblotting with pUL28- and pUL33-specific antibodies. The results, shown in Fig. 6, indicated that pUL28 antibody readily coimmunoprecipitated transiently expressed pUL33 of HSV-1(mP) in lysates held at both 34 and 39°C. Although the mutant pUL33 from ts8-22 was coimmunoprecipitated with pUL28-specific antibody at 34°C, these proteins coimmunoprecipitated very poorly at 39°C. These data indicate that the lesion in pUL33 largely precludes coimmunoprecipitation with pUL28 at the nonpermissive temperature and that this effect occurs independently of other viral functions.
![]() View larger version (53K): [in a new window] |
FIG. 6. Immunoblots of transiently expressed pUL28 and pUL33 immunoprecipitated with pUL28-specific antibody. CV1 cells were transfected with pcDNA (lane 1) or UL28 (lanes 2 through 5) and UL33 expression plasmids as indicated. The cells were lysed 24 h later and reacted with pUL28-specific antisera. Purified immune complexes were electrophoretically separated on a denaturing gel and transferred to nitrocellulose, and the presence of pUL33 (top) and pUL28 (bottom) was determined by immunoblotting. pJB546 contains UL33 of HSV-1(mP); pJB pJB547 contains UL33 of ts8-22.
|
|
|
|---|
Normally, DNA-containing capsids are preferentially enveloped in HSV-1-infected cells, and envelopment of B capsids lacking DNA is uncommon (18). In contrast to this situation, we have shown that although the mutation in UL33 precludes DNA cleavage and packaging at the nonpermissive temperature, it does not preclude envelopment of B capsids at the inner nuclear membrane (Fig. 4). The ultrastructural appearance of these cells resembles that of Vero cells infected with UL15 and UL28 null mutants, in which ample enveloped capsids lacking DNA were also noted in the cytoplasm (3, 21). Thus, putative terminase components function in some way to preclude DNA-negative capsids from budding at the nuclear membrane.
The mutation identified in this study, UL33 (Thr-61-Pro), conferring a temperature-sensitive phenotype, was different from a previously described temperature-sensitive mutation in UL33 (Ile-17-Asn) that also precluded DNA cleavage and packaging at the nonpermissive temperature (2). Coincidentally, the temperature-sensitive mutation in UL15 also involves a change to proline (from serine 653) (3). In the absence of structural information, the reason why these mutations confer temperature-sensitive phenotypes must remain speculative. It is conceivable that the proline residues in pUL33 and UL15 would destabilize alpha helices or change local polarity, and these effects would be exacerbated to a critical level at higher temperatures. Along these lines, the sequences between positions 52 and 66 of pUL33 have a high probability of forming an alpha helix, according to the algorithm of Garnier and Robson, whereas the proline near amino acid 653 of pUL15 is predicted to decrease the otherwise high charge ratio in this region (data not shown).
We have previously shown that both pUL33 and pUL15 interact with pUL28 in the cytoplasm, with subsequent import of the complex into the nucleus (24). The failure of terminase components to coimmunoprecipitate at the nonpermissive temperature in cells infected with the mutants described here argues that the lethal effects of the mutations are attributable to an early failure to assemble the terminase complex at the nonpermissive temperature. Whether these conditions also affect nuclear import in a later step remains to be tested. The observation that the UL33 mutation did not preclude coimmunoprecipitation of pUL15 with pUL28 antibody at the nonpermissive temperature further supports previous conclusions that pUL28 and pUL15 interact directly, even in the absence of pUL33 (23). In contrast, pUL33 can interact with pUL15 only through its interaction with pUL28. This is potentially consistent with the observation that levels of pUL28 were reduced more significantly than levels of pUL15 in cells infected with the UL33 mutant at the nonpermissive temperature.
Previous results have shown that the presence of pUL33 augments the pUL15-pUL28 interaction and that pUL28 is necessary and sufficient for pUL33 stability (23). The current studies also suggest that an important role for pUL33 is to interact with pUL28 to allow DNA packaging to proceed. Whether this reflects a role in mediating correct pUL28 folding or as an essential part of the DNA binding component of the terminase awaits biochemical testing. Some data presented here may reflect a role for pUL33 in precluding dysfunctional aggregation of pUL28 and pUL15. Specifically, the data shown in Fig. 5 suggest that at the permissive temperature, more pUL15 is immunoprecipitated with pUL28-specific antibody from cells infected with the UL33 temperature-sensitive mutant ts8-22 than from cells infected with wild-type HSV-1(mP). Interestingly, the increased immunoprecipitation of pUL15 and pUL28 did not correspond to a greatly increased amount of coimmunoprecipitated pUL33 (Fig. 5B, lane 6), suggesting that some pUL15-pUL28 complexes lack pUL33 under these circumstances. We sequenced UL15, UL28, and UL33 in both HSV-1(mP) and ts8-22 and found no differences other than the mutation in codon 61 of UL33 already noted in Fig. 2. Thus, compensating mutations in UL15 and UL28 are not responsible for the enhanced coimmunoprecipitation of the encoded proteins. We speculate that the mutation in pUL33 compromises the normal interaction between pUL15 and pUL28 even at the permissive temperature but that normal complexes are also made that are sufficient to support DNA cleavage and packaging. Thus, some pUL15 may interact with pUL28 that has become misfolded in the absence of pUL33, and failure of pUL15 to dissociate from this misfolded pUL28 would be expected to cause enhanced coimmunoprecipitation at steady state. Although we favor this scenario, we cannot exclude the possibilities that the pUL33 mutation enhances production of pUL28 and pUL15 or increases formation of functional pUL15/pUL28 complexes at the permissive temperature.
These studies were supported by public health services grants GM50740 (to J.D.B.) and CA 88860 (to B.R) from the National Institutes of Health.
Published ahead of print on 3 October 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»